159 related articles for article (PubMed ID: 34816127)
1. Identifying tumorigenic non-coding mutations through altered
Cheng Z; Vermeulen M; Rollins-Green M; Babak T; DeVeale B
STAR Protoc; 2021 Dec; 2(4):100934. PubMed ID: 34816127
[TBL] [Abstract][Full Text] [Related]
2. Candidate Cancer Driver Mutations in Distal Regulatory Elements and Long-Range Chromatin Interaction Networks.
Zhu H; Uusküla-Reimand L; Isaev K; Wadi L; Alizada A; Shuai S; Huang V; Aduluso-Nwaobasi D; Paczkowska M; Abd-Rabbo D; Ocsenas O; Liang M; Thompson JD; Li Y; Ruan L; Krassowski M; Dzneladze I; Simpson JT; Lupien M; Stein LD; Boutros PC; Wilson MD; Reimand J
Mol Cell; 2020 Mar; 77(6):1307-1321.e10. PubMed ID: 31954095
[TBL] [Abstract][Full Text] [Related]
3. Identification of High-Impact cis-Regulatory Mutations Using Transcription Factor Specific Random Forest Models.
Svetlichnyy D; Imrichova H; Fiers M; Kalender Atak Z; Aerts S
PLoS Comput Biol; 2015 Nov; 11(11):e1004590. PubMed ID: 26562774
[TBL] [Abstract][Full Text] [Related]
4. OncoBase: a platform for decoding regulatory somatic mutations in human cancers.
Li X; Shi L; Wang Y; Zhong J; Zhao X; Teng H; Shi X; Yang H; Ruan S; Li M; Sun ZS; Zhan Q; Mao F
Nucleic Acids Res; 2019 Jan; 47(D1):D1044-D1055. PubMed ID: 30445567
[TBL] [Abstract][Full Text] [Related]
5. Cancer regulatory variation.
Hennessey RC; Brown KM
Curr Opin Genet Dev; 2021 Feb; 66():41-49. PubMed ID: 33422949
[TBL] [Abstract][Full Text] [Related]
6. Cis-regulatory somatic mutations and gene-expression alteration in B-cell lymphomas.
Mathelier A; Lefebvre C; Zhang AW; Arenillas DJ; Ding J; Wasserman WW; Shah SP
Genome Biol; 2015 Apr; 16(1):84. PubMed ID: 25903198
[TBL] [Abstract][Full Text] [Related]
7. Whole-genome sequencing of multiple myeloma reveals oncogenic pathways are targeted somatically through multiple mechanisms.
Hoang PH; Dobbins SE; Cornish AJ; Chubb D; Law PJ; Kaiser M; Houlston RS
Leukemia; 2018 Nov; 32(11):2459-2470. PubMed ID: 29654271
[TBL] [Abstract][Full Text] [Related]
8. OncodriveFML: a general framework to identify coding and non-coding regions with cancer driver mutations.
Mularoni L; Sabarinathan R; Deu-Pons J; Gonzalez-Perez A; López-Bigas N
Genome Biol; 2016 Jun; 17(1):128. PubMed ID: 27311963
[TBL] [Abstract][Full Text] [Related]
9. Mining the coding and non-coding genome for cancer drivers.
Li J; Drubay D; Michiels S; Gautheret D
Cancer Lett; 2015 Dec; 369(2):307-15. PubMed ID: 26433158
[TBL] [Abstract][Full Text] [Related]
10. Identifying DNase I hypersensitive sites as driver distal regulatory elements in breast cancer.
D Antonio M; Weghorn D; D Antonio-Chronowska A; Coulet F; Olson KM; DeBoever C; Drees F; Arias A; Alakus H; Richardson AL; Schwab RB; Farley EK; Sunyaev SR; Frazer KA
Nat Commun; 2017 Sep; 8(1):436. PubMed ID: 28874753
[TBL] [Abstract][Full Text] [Related]
11. Pathway and network analysis of more than 2500 whole cancer genomes.
Reyna MA; Haan D; Paczkowska M; Verbeke LPC; Vazquez M; Kahraman A; Pulido-Tamayo S; Barenboim J; Wadi L; Dhingra P; Shrestha R; Getz G; Lawrence MS; Pedersen JS; Rubin MA; Wheeler DA; Brunak S; Izarzugaza JMG; Khurana E; Marchal K; von Mering C; Sahinalp SC; Valencia A; ; Reimand J; Stuart JM; Raphael BJ;
Nat Commun; 2020 Feb; 11(1):729. PubMed ID: 32024854
[TBL] [Abstract][Full Text] [Related]
12. Non-coding transcription at cis-regulatory elements: computational and experimental approaches.
Simonatto M; Barozzi I; Natoli G
Methods; 2013 Sep; 63(1):66-75. PubMed ID: 23542771
[TBL] [Abstract][Full Text] [Related]
13. CNCDatabase: a database of non-coding cancer drivers.
Liu EM; Martinez-Fundichely A; Bollapragada R; Spiewack M; Khurana E
Nucleic Acids Res; 2021 Jan; 49(D1):D1094-D1101. PubMed ID: 33095860
[TBL] [Abstract][Full Text] [Related]
14. Promoter capture Hi-C-based identification of recurrent noncoding mutations in colorectal cancer.
Orlando G; Law PJ; Cornish AJ; Dobbins SE; Chubb D; Broderick P; Litchfield K; Hariri F; Pastinen T; Osborne CS; Taipale J; Houlston RS
Nat Genet; 2018 Oct; 50(10):1375-1380. PubMed ID: 30224643
[TBL] [Abstract][Full Text] [Related]
15. DrGaP: a powerful tool for identifying driver genes and pathways in cancer sequencing studies.
Hua X; Xu H; Yang Y; Zhu J; Liu P; Lu Y
Am J Hum Genet; 2013 Sep; 93(3):439-51. PubMed ID: 23954162
[TBL] [Abstract][Full Text] [Related]
16. Identification of constrained cancer driver genes based on mutation timing.
Sakoparnig T; Fried P; Beerenwinkel N
PLoS Comput Biol; 2015 Jan; 11(1):e1004027. PubMed ID: 25569148
[TBL] [Abstract][Full Text] [Related]
17. OncoCis: annotation of cis-regulatory mutations in cancer.
Perera D; Chacon D; Thoms JA; Poulos RC; Shlien A; Beck D; Campbell PJ; Pimanda JE; Wong JW
Genome Biol; 2014; 15(10):485. PubMed ID: 25298093
[TBL] [Abstract][Full Text] [Related]
18. Dr.Nod: computational framework for discovery of regulatory non-coding drivers in tissue-matched distal regulatory elements.
Tomkova M; Tomek J; Chow J; McPherson JD; Segal DJ; Hormozdiari F
Nucleic Acids Res; 2023 Feb; 51(4):e23. PubMed ID: 36625266
[TBL] [Abstract][Full Text] [Related]
19. A Dual Model for Prioritizing Cancer Mutations in the Non-coding Genome Based on Germline and Somatic Events.
Li J; Poursat MA; Drubay D; Motz A; Saci Z; Morillon A; Michiels S; Gautheret D
PLoS Comput Biol; 2015 Nov; 11(11):e1004583. PubMed ID: 26588488
[TBL] [Abstract][Full Text] [Related]
20. The search for cis-regulatory driver mutations in cancer genomes.
Poulos RC; Sloane MA; Hesson LB; Wong JW
Oncotarget; 2015 Oct; 6(32):32509-25. PubMed ID: 26356674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
